Cargando…
Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery
PURPOSE: Remission of type 2 diabetes (T2D) can be achieved by many, but not all, people following bariatric/metabolic surgery. The mechanisms underlying T2D remission remain incompletely understood. This observational study aimed to identify novel weight-loss independent clinical, metabolic and gen...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687127/ https://www.ncbi.nlm.nih.gov/pubmed/37910328 http://dx.doi.org/10.1007/s11695-023-06905-8 |
_version_ | 1785151914526113792 |
---|---|
author | Chaiyasoot, Kusuma Sakai, Naomi S. Zakeri, Roxanna Makaronidis, Janine Crisóstomo, Luís Alves, Marco G. Gan, Wei Firman, Chloe Jassil, Friedrich C. Hall-Craggs, Margaret A. Taylor, Stuart A. Batterham, Rachel L. |
author_facet | Chaiyasoot, Kusuma Sakai, Naomi S. Zakeri, Roxanna Makaronidis, Janine Crisóstomo, Luís Alves, Marco G. Gan, Wei Firman, Chloe Jassil, Friedrich C. Hall-Craggs, Margaret A. Taylor, Stuart A. Batterham, Rachel L. |
author_sort | Chaiyasoot, Kusuma |
collection | PubMed |
description | PURPOSE: Remission of type 2 diabetes (T2D) can be achieved by many, but not all, people following bariatric/metabolic surgery. The mechanisms underlying T2D remission remain incompletely understood. This observational study aimed to identify novel weight-loss independent clinical, metabolic and genetic factors that associate with T2D remission using comprehensive phenotyping. MATERIALS AND METHODS: Ten patients without T2D remission (non-remitters) were matched to 10 patients with T2D remission (remitters) for age, sex, type of surgery, body weight, BMI, post-operative weight loss, duration from surgery and duration of T2D. Detailed body composition assessed using magnetic resonance imaging, gut hormones, serum metabolomics, insulin sensitivity, and genetic risk scores for T2D and anthropometric traits were assessed. RESULTS: Remitters had significantly greater β-cell function and circulating acyl ghrelin levels, but lower visceral adipose tissue (VAT): subcutaneous adipose tissue (SAT) ratio than non-remitters. Branched-chain amino acids (BCAAs) and VLDL particle size were the most discriminant metabolites between groups. A significant positive correlation between, VAT area, VAT:SAT ratio and circulating levels of BCAAs was observed, whereas a significant negative correlation between BCAAs and β-cell function was revealed. CONCLUSION: We highlight a potentially novel relationship between VAT and BCAAs, which may play a role in glucoregulatory control. Improvement in β-cell function, and the role ghrelin plays in its recovery, is likely another key factor influencing T2D remission post-surgery. These findings suggest that adjunctive approaches that target VAT loss and restoration of BCAA metabolism might achieve higher rates of long-term T2D remission post-surgery. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11695-023-06905-8. |
format | Online Article Text |
id | pubmed-10687127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-106871272023-12-01 Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery Chaiyasoot, Kusuma Sakai, Naomi S. Zakeri, Roxanna Makaronidis, Janine Crisóstomo, Luís Alves, Marco G. Gan, Wei Firman, Chloe Jassil, Friedrich C. Hall-Craggs, Margaret A. Taylor, Stuart A. Batterham, Rachel L. Obes Surg Original Contributions PURPOSE: Remission of type 2 diabetes (T2D) can be achieved by many, but not all, people following bariatric/metabolic surgery. The mechanisms underlying T2D remission remain incompletely understood. This observational study aimed to identify novel weight-loss independent clinical, metabolic and genetic factors that associate with T2D remission using comprehensive phenotyping. MATERIALS AND METHODS: Ten patients without T2D remission (non-remitters) were matched to 10 patients with T2D remission (remitters) for age, sex, type of surgery, body weight, BMI, post-operative weight loss, duration from surgery and duration of T2D. Detailed body composition assessed using magnetic resonance imaging, gut hormones, serum metabolomics, insulin sensitivity, and genetic risk scores for T2D and anthropometric traits were assessed. RESULTS: Remitters had significantly greater β-cell function and circulating acyl ghrelin levels, but lower visceral adipose tissue (VAT): subcutaneous adipose tissue (SAT) ratio than non-remitters. Branched-chain amino acids (BCAAs) and VLDL particle size were the most discriminant metabolites between groups. A significant positive correlation between, VAT area, VAT:SAT ratio and circulating levels of BCAAs was observed, whereas a significant negative correlation between BCAAs and β-cell function was revealed. CONCLUSION: We highlight a potentially novel relationship between VAT and BCAAs, which may play a role in glucoregulatory control. Improvement in β-cell function, and the role ghrelin plays in its recovery, is likely another key factor influencing T2D remission post-surgery. These findings suggest that adjunctive approaches that target VAT loss and restoration of BCAA metabolism might achieve higher rates of long-term T2D remission post-surgery. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11695-023-06905-8. Springer US 2023-11-01 2023 /pmc/articles/PMC10687127/ /pubmed/37910328 http://dx.doi.org/10.1007/s11695-023-06905-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Contributions Chaiyasoot, Kusuma Sakai, Naomi S. Zakeri, Roxanna Makaronidis, Janine Crisóstomo, Luís Alves, Marco G. Gan, Wei Firman, Chloe Jassil, Friedrich C. Hall-Craggs, Margaret A. Taylor, Stuart A. Batterham, Rachel L. Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title | Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title_full | Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title_fullStr | Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title_full_unstemmed | Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title_short | Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery |
title_sort | weight-loss independent clinical and metabolic biomarkers associated with type 2 diabetes remission post-bariatric/metabolic surgery |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687127/ https://www.ncbi.nlm.nih.gov/pubmed/37910328 http://dx.doi.org/10.1007/s11695-023-06905-8 |
work_keys_str_mv | AT chaiyasootkusuma weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT sakainaomis weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT zakeriroxanna weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT makaronidisjanine weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT crisostomoluis weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT alvesmarcog weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT ganwei weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT firmanchloe weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT jassilfriedrichc weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT hallcraggsmargareta weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT taylorstuarta weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery AT batterhamrachell weightlossindependentclinicalandmetabolicbiomarkersassociatedwithtype2diabetesremissionpostbariatricmetabolicsurgery |